Engineering Magnetosomes for High-Performance Cancer Vaccination
Lists
Only you see this
Abstract
A novel cancer vaccine is developed by using Fe<sub>3</sub>O<sub>4</sub> magnetic nanoclusters (MNCs) as the core and cancer cell membranes decorated with anti-CD205 as the cloak. Because of the superparamagnetism and magnetization of MNCs, it is first achieved for the magnetic retention of vaccine in the lymph nodes with a magnetic resonance imaging (MRI) guide, which opened the time window for antigen uptake by dendritic cells (DCs). Meanwhile, the camouflaged cancer cell membranes serve as a reservoir of various antigens, enabling subsequent multiantigenic response. Additionally, the decorated anti-CD205 direct more vaccine into CD8<sup>+</sup> DCs, facilitating the major histocompatibility complex (MHC) I cross-presentation. These unique advantages together lead to a great proliferation of T cells with superior clonal diversity and cytotoxic activity. As a result, potent prophylactic and therapeutic effects with few abnormalities are observed on five different tumor models. Therefore, such a cancer-derived magnetosome with the integration of various recent nanotechnologies successfully demonstrates its promise for safe and high-performance cancer vaccination.
BibTeX
@inproceedings{li2019engineering,
author = {Feng Li and Weidong Nie and Fan Zhang and Guihong Lu and Chengliang Lv and Yanlin Lv and Weier Bao and Lijun Zhang and Shuang Wang and Xiaoyong Gao and Wei Wei and Hai‐Yan Xie},
title = {{Engineering Magnetosomes for High-Performance Cancer Vaccination}},
booktitle = {ACS},
year = {2019},
doi = {10.1021/acscentsci.9b00060},
}Loading related content...